Notes
J . Org. Chem., Vol. 66, No. 9, 2001 3203
it was treated with H2O (7 mL) and extracted with ether. The
organic phase was washed with H2O and saturated NaCl and
dried. After evaporation of the solvent, the oxiranyl ethers
(6e,g,i) were purified by chromatography; only the erythro
isomer was fully characterized and further used.
L-(+)-diisopropyltartrate (5.34 g, 23 mmol) were mixed under
N2 and cooled to -23 °C. 1-[(tert-Butyldimethylsilyl)oxy]-3-buten-
2-ol (3.84 g, 19 mmol) was then added and the mixture
maintained at -23 °C for 30 min before t-BuOOH (2.72 mL of a
5.5 M solution in decane, dried over molecular sieves, 15 mmol)
was slowly added. After 3 days, the cold reaction mixture was
poured into a precooled (-20 °C) solution consisting of 130 mL
of reagent-grade acetone containing 5.5 mL of water. The
resulting mixture was stirred and allowed to warm to 25 °C.
Stirring was continued until the formation of an opaque solution
that was filtered. After evaporation of the solvent, the residue
was diluted with 130 mL of ether, and then, after cooling to 0
°C, 52 mL of 1 N sodium hydroxide solution was added. This
two-phase mixture was stirred at 0 °C for 0.5 h, and then the
ether phase was washed with brine and dried (Na2SO4). After
evaporation of the solvent, 2.52 g of a 60:40 mixture of (2R)-1-
[(tert-butyldimethylsilyl)oxy]-3-buten-2-ol and anti-(2S,3R)-1-
[(tert-butyldimethylsilyl)oxy]-3,4-epoxy-2-butanol was obtained,
and the compounds were separated by chromatography (petro-
leum ether/ethyl acetate 4:1) to afford 1.14 g of pure R-allylic
alcohol and 0.70 g (42%) of pure epoxy alcohol. 1H NMR (CDCl3,
200 MHz) δ: 3.76 (2H, AB system); 3.55 (1H, app q, J ) 5.0
Hz); 3.04 (1H, ddd, J ) 5.4, 4.0, 2.6 Hz); 2.81 (1H, dd, J ) 5.2,
4.0 Hz); 2.76 (1H, dd, J ) 5.2, 2.6 Hz); 2.44 (1H, bs); 0.91 (9H,
s); 0.09 (6H, s).
3-(2-P r op en oxy)-1,2-ep oxyocta n e 6e. Purification: eluent
petroleum ether/ethyl acetate 15:1; yield 56%; erythro:threo 78:
22. 1H NMR (CDCl3, 200 MHz): erythro: 5.90 (1H, ddt, J ) 17.2,
10.2, 5.6 Hz); 5.25 (1H, app dq, J ) 17.2, 1.8 Hz); 5.16 (1H, dq,
J ) 10.2, 1.8 Hz); 4.04 (2H, AB system); 3.2-3.1 (1H, m); 2.89
(1H, ddd, J ) 5.4, 4.0, 2.6 Hz); 2.79 (1H, dd, J ) 5.4, 4.0 Hz);
2.72 (1H, dd, J ) 5.4, 2.6 Hz); 1.6-1.2 (8H, m); 0.89 (3H, t, J )
6.6 Hz). 13C NMR (CDCl3, 75.45 MHz) δ: 135.1; 116.8; 78.1; 71.2;
53.4; 45.6; 32.8; 31.8; 24.8; 22.5; 14.0. MS (m/z): 183 (0.01, M+
- 1); 141 (37, M+ - C3H7); 99 (57); 81 (49); 71 (82); 69 (28); 68
(21); 67 (33); 57 (71); 55 (100). Anal. Calcd for C11H20O2: C, 71.70;
H, 10.94. Found: C, 71.42; H, 10.77.
3-Ben zyloxy-1,2-ep oxyocta n e 6g.25 Purification: eluent
petroleum ether/ ethyl acetate 15:1; yield 55%; erythro:threo 80:
1
20. H NMR (CDCl3, 200 MHz): erythro: 7.4-7.2 (5H, m); 4.58
(2H, AB system); 3.3-3.2 (1H, m); 2.93 (1H, ddd, J ) 5.6, 3.8,
2.6); 2.78 (1H, dd, J ) 5.4, 3.8); 2.72 (1H, dd, J ) 5.4, 2.6); 1.7-
1.2 (8H, m); 0.89 (3H, t, J ) 7.0). 13C NMR (CDCl3, 75.45 MHz)
δ: 138.6; 128.4; 127.7; 127.6; 78.1; 72.3; 53.6; 45.6; 32.8; 31.8;
24.8; 22.5; 14.0. MS (m/z): 234 (0.75, M+); 127 (2.2, M+
-
OCH2C6H5); 107 (61); 91 (100, C7H7+); 65 (26); 43 (25); 41 (27).
3-(2-P r op yn oxy)-1,2-ep oxyocta n e 6i.26 Purification: eluent
petroleum ether/ ethyl acetate 10:1; yield: 54%. erythro:threo
80:20. 1H NMR (CDCl3, 200 MHz) (erythro): 4.22 (2H, AB of
ABX); 3.4-3.3 (1H, m); 2.90 (1H, ddd, J ) 5.0, 3.2, 2.6); 2.8-2.7
(2H, m); 2.41 (1H, app t, J ) 2.6); 1.6-1.2 (8H, m); 0.89 (3H, t,
J ) 6.6). 13C NMR (CDCl3, 75.45 MHz) δ: 80.0; 77.4; 74.2; 57.3;
53.1; 45.4; 32.6; 31.8; 24.6; 22.5; 14.0. MS (m/z): 139 (100, M+
- C3H7); 111 (69, M+ - C5H11); 99 (40); 83 (38); 82 (28); 81 (58);
71 (72); 69 (43); 68 (32); 67 (56); 57 (44); 56 (34); 55 (100); 54
(68), 53 (98).
2. P r ep a r a tion of Oxir a n yl Eth er s 6f,h ,j. 3-Bu ten e-1,2-
d iol.27 A mixture of 2-butene-1,4-diol (25 g, 0.28 mol), water (10
mL), concentrated sulfuric acid (0.14 mL), and mercuric sulfate
(0.10 g) was heated under reflux. After 1.5 h, the reaction
mixture was cooled to 0 °C, neutralized with 10% sodium
hydroxide to pH 7, and then distilled. The first fraction, distilled
between 50 and 55 °C/15 mmHg, contained water, the second
fraction collected between 110 and 115 °C/15 mmHg, contained
3-buten-1,2-diol (13 g, 52%) as a colorless liquid, and the third
fraction, collected between 125 and 130 °C/15 mmHg, had traces
of unreacted starting material. 3-Butene-1,2-diol. 1H NMR
(CDCl3, 200 MHz) δ: 5.86 (1H, ddd, J ) 17.6, 10.6, 5.8); 5.37
(1H, app dt, J ) 17.6, 1.4); 5.24 (1H, app dt, J ) 10.6, 1.6); 4.3-
4.2 (1H, m); 3.69 (1H, dd, J ) 11.4, 3.6); 3.51 (1H, dd, J ) 11.4,
7.2), 2.13 (2H, s).
1-[(ter t-Bu t yld im et h ylsilyl)oxy]-3-b u t en -2-ol.28 The 3-
butene-1,2-diol (2.64 g, 30 mmol) was dissolved in THF (48 mL),
and after the solution was cooled to -78 °C, BuLi (18.7 mL of
1.6 M solution in hexane, 30 mmol) was slowly added. After an
additional 15 min, tert-butyldimethylsilyl chloride (4.53 g, 30
mmol) was added, and the mixture was warmed to 25 °C and
then stirred for 15 h. After evaporation of the solvent, the residue
was purified by chromatography, eluent petroleum ether/ethyl
acetate 7:1 affording 3.84 g (63%) of monoprotected diol. 1H NMR
(CDCl3, 200 MHz) δ: 5.81 (1H, ddd, J ) 17.6, 10.6, 5.8); 5.34
(1H, app dt, J ) 17.4, 1.4); 5.19 (1H, app dt, J ) 10.6, 1.4); 4.2-
4.1 (1H, m); 3.66 (1H, dd, J ) 10.0, 3.6); 3.44 (1H, dd, J ) 10.0,
7.8); 2.3-2.1 (1H, bs); 0.90 (9H, s); 0.08 (6H, s).
P r ep a r a tion of Oxir a n yl Eth er s. Gen er a l P r oced u r e.
Meth od A. NaH (0.08 g, 3.2 mmol) suspended in THF (5 mL)
was added to a precooled (-5 °C) solution of anti-(2S,3R)-1-[(tert-
butyldimethylsilyl)oxy]-3,4-epoxy-2-butanol (0.70 g, 3.2 mmol)
in THF (5 mL). After 30 min at -5 °C, cat. Bu4NI and then the
suitable halide (3.2 mmol) were added, and the mixture was
stirred for 3 h at 25 °C before it was treated with water-ice
and extracted with ether. The organic phase was washed with
brine and dried.
Meth od B. A suspension of epoxide (0.70 g, 3.2 mmol),
benzyltriethylammonium chloride (0.51 g, 2.24 mmol), and the
suitable halide (7.0 mmol) in benzene (7 mL) and 70% aq NaOH
(7 mL) was stirred vigorously at 25 °C for 14 h. The mixture
was extracted with ether, and the organic phase was washed
with water and brine and dried.
a n t i-(2S ,3R )-2-(2-P r op e n oxy)-1-[(t er t -b u t yld im e t h yl-
silyl)oxy]-3,4-ep oxybu ta n e 6f. Compound 6f was prepared
according to procedure A, giving 0.69 g of crude which was then
purified by column chromatography (petroleum ether/ethyl
acetate 7:1), affording 0.58 g of 6f (70%) as an anti:syn (70:30)
mixture. An ti: 1H NMR (CDCl3, 200 MHz) δ: 5.90 (1H, ddt,
J ) 17.2, 10.2, 5.6 Hz); 5.58 (1H, app dq, J ) 17.2, 1.8 Hz); 5.37
(1H, app dq, J ) 10.2, 1.8 Hz); 4.10 (2H, AB system); 3.75 (2H,
app d, J ) 5.6 Hz); 3.35 (1H, m); 3.1-3.0 (1H, m); 2.77 (2H, app
d, J ) 3.4 Hz); 0.90 (9H, s); 0.07 (6H, s). Anal. Calcd for C13H26O3-
Si: C, 60.42; H, 10.14. Found: C, 60.32; H, 10.27. Syn : 1H NMR
(CDCl3, 200 MHz) δ: 6.0-5.8 (1H, m); 5.4-5.1 (2H, m); 4.02
(2H, AB system); 3.9-3.7 (1H, m); 3.52 (1H,app s); 3.49 (1H,
AB system); 3.1-3.0 (1H, m); 2.7-2.6 (2H, m); 0.87 (9H, s); 0.07
(6H, s). Only the anti isomer was further used.
a n ti-(2S,3R)-2-Ben zyloxy-1-[(ter t-b u t yld im et h ylsilyl)-
oxy]-3,4-ep oxybu ta n e 6h . Compound 6h was prepared accord-
ing to procedure A, giving 0.80 g of crude which was then
purified by column chromatography (petroleum ether/ethyl
acetate 10:1), affording 0.59 g of 6h (60%) as an anti:syn (71:
1
29) mixture. An ti: H NMR (CDCl3, 200 MHz) δ: 7.4-7.2 (5H,
m); 4.65 (2H, AB system); 3.78 (2H, app d, J ) 5.0 Hz); 3.41
(1H, app q, J ) 4.9 Hz); 3.08 (1H, ddd, J ) 6.6, 3.6, 2.4 Hz);
2.8-2.7 (2H, m); 0.90 (9H, s); 0.06 (6H, s). Anal. Calcd for
C
17H28O3Si: C, 66.19; H, 9.15. Found: C, 66.32; H, 9.27. Syn :
a n ti-(2S,3R)-1-[(ter t-bu tyld im eth ylsilyl)oxy]-3,4-ep oxy-
1H NMR (CDCl3, 200 MHz) δ: 7.4-7.2 (5H, m); 4.57 (2H, AB
system); 3.9-3.8 (1H, m); 3.54 (2H, app d, J ) 5.0 Hz); 3.1-3.0
(1H, m); 2.8-2.7 (2H, m); 0.87 (9H, m); 0.05 (6H, m).
2-bu ta n ol.29 Ti(i-OPr)4 (5.40 g, 19 mmol), CH2Cl2 (65 mL), and
Only the anti isomer was further used.
(25) Sato, F.; Kobayashi, Y.; Takahashi, O.; Osamu, C.; Tsunehisa,
T.; Takeda, Y.; Kusakabe, M. J . Chem. Soc., Chem. Commun. 1985,
1636.
(26) Maiti, G.; Roy, S. C. J . Chem. Soc., Perkin Trans. 1 1996, 403.
(27) Rama Rao, A. V.; Gurjar, M. K.; Bose, D. S.; Devi, R. R. J . Org.
Chem. 1991, 56, 1320.
(28) Crilley, M. M. L.; Golding, B. T.; Pierpoint, C. J . Chem. Soc.,
Perkin Trans. 1 1988, 2061.
(29) Gurjar, M. K.; Devi, N. R. Tetrahedron: Asymmetry 1994, 5,
755.
a n t i-(2S ,3R )-2-(2-P r op yn oxy)-1-[(t er t -b u t yld im e t h yl-
silyl)oxy]-3,4-ep oxybu ta n e 6j. Compound 6j was prepared
according to procedure B, giving 0.17 g of crude which was then
purified by column chromatography (petroleum ether/ethyl
acetate 7:1), affording 0.15 g of 6j (70%) as an anti:syn (71:29)
mixture. An ti: 1H NMR (CDCl3, 200 MHz) δ: 4.29 (2H, d, J )
2.2 Hz); 3.8-3.7 (2H, m); 3.52 (1H, m); 3.05 (1H, ddd, J ) 6.6,
5.2, 3.4 Hz); 2.80 (1H, app d, J ) 2.8 Hz); 2.71 (1H, app d, J )